{"slideshow_credits": null, "snippet": "Two companies are asking the Food and Drug Administration for approval to market tablets or liquids to treat allergies, drugs which are already available in Europe.", "abstract": "Drug makers Merck and Stallergenes have asked Food and Drug Administration for approval to market tablets or liquids to treat pollen and other allergies; drugs, which would replace long-used injections, are already available in Europe.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/12/06/business/treating-allergies-with-pills-or-drops-instead-of-shots.html", "lead_paragraph": "Two companies are asking the Food and Drug Administration for approval to market tablets or liquids to treat allergies, drugs which are already available in Europe.", "headline": {"main": "Treating Allergies With Pills or Drops Instead of Shots", "print_headline": "Treating Allergies With Pills or Drops Instead of Shots"}, "_id": "52a1196038f0d84e53acb956", "word_count": "1391", "multimedia": [{"height": 126, "url": "images/2013/12/06/business/ALLERGY/ALLERGY-thumbWide-v2.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/12/06/business/ALLERGY/ALLERGY-thumbWide-v2.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 392, "url": "images/2013/12/06/business/Allergyjp/Allergyjp-articleLarge.jpg", "legacy": {"xlarge": "images/2013/12/06/business/Allergyjp/Allergyjp-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "392"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2013/12/06/business/ALLERGY/ALLERGY-thumbStandard-v2.jpg", "legacy": {"thumbnail": "images/2013/12/06/business/ALLERGY/ALLERGY-thumbStandard-v2.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-12-06T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Stallergenes SA", "name": "organizations", "is_major": "Y", "rank": "5"}, {"value": "Clinical Trials", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Allergies", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Merck & Company Inc", "name": "organizations", "is_major": "Y", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}